HAJJI, Khadija, Jiří SEDMÍK, Anna CHERIAN, Damiano AMORUSO, Liam KEEGAN and Mary Anne O'CONNELL. ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations. RNA. Cold Spring Harbor: Cold Spring Harbor Laboratory Press, 2022, vol. 28, No 10, p. 1281-1297. ISSN 1355-8382. Available from: https://dx.doi.org/10.1261/rna.079266.122.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name ADAR2 enzymes: efficient site-specific RNA editors with gene therapy aspirations
Authors HAJJI, Khadija (788 Tunisia, belonging to the institution), Jiří SEDMÍK (203 Czech Republic, belonging to the institution), Anna CHERIAN (356 India, belonging to the institution), Damiano AMORUSO (380 Italy, belonging to the institution), Liam KEEGAN (372 Ireland, belonging to the institution) and Mary Anne O'CONNELL (372 Ireland, guarantor, belonging to the institution).
Edition RNA, Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 2022, 1355-8382.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 10608 Biochemistry and molecular biology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 4.500
RIV identification code RIV/00216224:14740/22:00129412
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1261/rna.079266.122
UT WoS 000859478500001
Keywords in English ADAR; ADARB1; dsRNA; recoding RNA editing; neurons
Tags rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 3/4/2023 10:45.
Abstract
The adenosine deaminase acting on RNA (ADAR) enzymes are essential for neuronal function and innate immune control. ADAR1 RNA editing prevents aberrant activation of antiviral dsRNA sensors through editing of long, double-stranded RNAs (dsRNAs). In this review, we focus on the ADAR2 proteins involved in the efficient, highly site-specific RNA editing to recode open reading frames first discovered in the GRIA2 transcript encoding the key GLUA2 subunit of AMPA receptors; ADAR1 proteins also edit many of these sites. We summarize the history of ADAR2 protein research and give an up-to-date review of ADAR2 structural studies, human ADARBI (ADAR2) mutants causing severe infant seizures, and mouse disease models. Structural studies on ADARs and their RNA substrates facilitate current efforts to develop ADAR RNA editing gene therapy to edit disease-causing single nucleotide polymorphisms (SNPs). Artificial ADAR guide RNAs are being developed to retarget ADAR RNA editing to new target transcripts in order to correct SNP mutations in them at the RNA level. Site-specific RNA editing has been expanded to recode hundreds of sites in CNS transcripts in Drosophila and cephalopods. In Drosophila and C. elegans, ADAR RNA editing also suppresses responses to self dsRNA.
Links
GA20-11101S, research and development projectName: Objasnění úlohy RNA-editačního enzymu ADAR1 v nových biologických drahách a určení jeho postranslační regulace.
Investor: Czech Science Foundation
GX21-27329X, research and development projectName: ADAR-dependentní RNA editace; Jak imunitní systém a mozek porušují Centrální Dogma.
Investor: Czech Science Foundation
956810, interní kód MUName: ROles of ePitranscriptomic in diseasES (Acronym: ROPES)
Investor: European Union, MSCA Marie Skłodowska-Curie Actions (Excellent Science)
PrintDisplayed: 24/7/2024 13:29